OpenURL Connection Search

Select item for more details and to access through your institution.

DPD status and fluoropyrimidines-based treatment: high activity matters too.
Published in:
2020
By:
- Chamorey, Emmanuel;
- Francois, Eric;
- Etienne, Marie-Christine;
- Ferrero, Jean-Marc;
- Peyrade, Frederic;
- Barranger, Emmanuel;
- Bozec, Alexandre;
- Largillier, Rémy;
- Cassuto, Ophelie;
- Viotti, Julien;
- Schiappa, Renaud;
- Milano, Gérard
Publication type:
journal article
Parkin differently regulates presenilin-1 and presenilin-2 functions by direct control of their promoter transcription.
Published in:
Journal of Molecular Cell Biology, 2013, v. 5, n. 2, p. 132, doi. 10.1093/jmcb/mjt003
By:
- Duplan, Eric;
- Sevalle, Jean;
- Viotti, Julien;
- Goiran, Thomas;
- Bauer, Charlotte;
- Renbaum, Paul;
- Levy-Lahad, Ephrat;
- Gautier, Clément A.;
- Corti, Olga;
- Leroudier, Nathalie;
- Checler, Frédéric;
- Alves da Costa, Cristine
Publication type:
Article
Optimizing drug development in oncology by clinical trial simulation: Why and how?
Published in:
Briefings in Bioinformatics, 2018, v. 19, n. 6, p. 1203, doi. 10.1093/bib/bbx055
By:
- Gal, Jocelyn;
- Milano, Gérard;
- Ferrero, Jean-Marc;
- Saâda-Bouzid, Esma;
- Viotti, Julien;
- Chabaud, Sylvie;
- Gougis, Paul;
- Tourneau, Christophe Le;
- Schiappa, Renaud;
- Paquet, Agnes
Publication type:
Article
CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas.
Published in:
2017
By:
- Dufies, Maeva;
- Giuliano, Sandy;
- Viotti, Julien;
- Borchiellini, Delphine;
- Cooley, Linsay S;
- Ambrosetti, Damien;
- Guyot, Mélanie;
- Ndiaye, Papa Diogop;
- Parola, Julien;
- Claren, Audrey;
- Schiappa, Renaud;
- Gal, Jocelyn;
- Frangeul, Antoine;
- Jacquel, Arnaud;
- Cassuto, Ophélie;
- Grépin, Renaud;
- Auberger, Patrick;
- Bikfalvi, Andréas;
- Milano, Gérard;
- Escudier, Bernard
Publication type:
journal article
Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study.
Published in:
Journal of Nuclear Medicine, 2017, v. 58, n. 8, p. 1249, doi. 10.2967/jnumed.116.184218
By:
- Zwarthoed, Colette;
- El-Galaly, Tarec Cristoffer;
- Canepari, Maria;
- Ouvrier, Matthieu John;
- Viotti, Julien;
- Ettaiche, Marc;
- Viviani, Simonetta;
- Rigacci, Luigi;
- Trentin, Livio;
- Rusconi, Chiara;
- Luminari, Stefano;
- Cantonetti, Maria;
- Bolis, Silvia;
- Borra, Anna;
- Darcourt, Jacques;
- Salvi, Flavia;
- Subocz, Edyta;
- Tajer, Joanna;
- Kulikowski, Waldemar;
- Malkowski, Bogdan
Publication type:
Article
Parkin acts as a transcription factor modulating presenilin-1 and presenilin-2 promoter transactivations.
Published in:
2013
By:
- Duplan, Eric;
- Sévalle, Jean;
- Viotti, Julien;
- Goiran, Thomas;
- Bauer, Charlotte;
- Renbaum, Paul;
- Levy-Lahad, Ephrat;
- Gautier, Clément A.;
- Corti, Olga;
- Leroudier, Nathalie;
- Checler, Frédéric;
- da Costa, Cristine Alves
Publication type:
Abstract

Found: 6

DPD status and fluoropyrimidines-based treatment: high activity matters too.

Parkin differently regulates presenilin-1 and presenilin-2 functions by direct control of their promoter transcription.

Optimizing drug development in oncology by clinical trial simulation: Why and how?

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas.

Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study.

Parkin acts as a transcription factor modulating presenilin-1 and presenilin-2 promoter transactivations.